ACSL1 and breast cancer: ACSL1 exhibits elevated expression levels in hepatocellular carcinoma, BC, ovarian cancer, and colorectal cancer, while displays low expression in esophageal adenocarcinoma and renal cell carcinoma (Zhang and Wang, 2023).